Solutions to COVID-19 Business Continuity and Fast Track Trial Challenges – Clinical and Regulatory Aspects

ON DEMAND

Who should watch: Clinical and Regulatory executives affected with business continuity issues and/or are working on COVID-19 trials

Structure: Presentation and Q&A Roundtable – 45 min

What you will learn:

• Status on COVID-19 guidelines from major health authorities (FDA, EMA, MHRA etc.)
• Fast track implications for IND and CTA filings to start trials without delay
• Impact for clinical trials – rapid deployment of teams, accelerated document processing, maintaining required quality
• Chances and potential of automation tools to reduce trial time
• Planning ahead for NDA and MAA filings to ensure quality submissions and a speedy start to the review process

Major Webinar Highlights:

• Presentation of current COVID-19 projects Phlexglobal is working on. Sharing of best practices, key metrics, learnings and results.